{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-06T12:22:06.197606+00:00",
  "news": [
    {
      "title": "Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen",
      "link": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPOURKbzJfc1BFUkM4VThkel81UFhMWXVwVVczMEVsX2JoeUZLU0Zxbm5acEZQM2Z1ckEtSldKY3luT3I2em5LX0FDcGpSaW9OSVFSVHRIckl4SHl3LWNDa21VcW1EdVZPX3RJZXhmREJUb0lQaFp4QlNIV2NOcXZQazdVSnZyYTlEM1ZLQmlGaW5OZGo4QlhtSE1DcXk1dWs3blkySUZTZGh5RldlcFlqTW1qM1ItSEE1RHc1ZEotQk10dU1QdTQ0NFBJQnYtcEdHUkFZRnBYMzdwTzJFcmFUZWJKMDhZdGpUUHc?oc=5\" target=\"_blank\">Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-05T14:11:59+00:00",
      "source": "Amgen"
    },
    {
      "title": "Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE5ra2Z4cEtDU3pZVE1FUnRpclVxc05xRlJLcmhMR2hZc2dDZ1doY1dsZUhWLWZBb2k2bjJUcDZ1TV8zbVI4RjFrRkFDQ3lBaGdCR1YtMlF0OXVsS0w1bkdmRFlOU1dyWF8wcFAyU0IyYUt5bEJiU0gwTkk1NA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE5ra2Z4cEtDU3pZVE1FUnRpclVxc05xRlJLcmhMR2hZc2dDZ1doY1dsZUhWLWZBb2k2bjJUcDZ1TV8zbVI4RjFrRkFDQ3lBaGdCR1YtMlF0OXVsS0w1bkdmRFlOU1dyWF8wcFAyU0IyYUt5bEJiU0gwTkk1NA?oc=5\" target=\"_blank\">Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-05T14:00:03+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-05T18:48:38+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen: Stagnation And The IRS Are Coming (NASDAQ:AMGN) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPdEl1S2JIRi1hWGhGWXJKNFZNbjVWZmhGblgybTlDd09mczhkbmd5d1EzRkRpN19zQ2ZvVzl4ZjBmbFZfT0d0cUtkNlozZHFqY3FjR2hvZnJ6Q2RsRjZQYURaZVBCOGMzbDIta3NwRHFSNEdJRVcyUWlZVkZRQkVrQkxDZEtMUWs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPdEl1S2JIRi1hWGhGWXJKNFZNbjVWZmhGblgybTlDd09mczhkbmd5d1EzRkRpN19zQ2ZvVzl4ZjBmbFZfT0d0cUtkNlozZHFqY3FjR2hvZnJ6Q2RsRjZQYURaZVBCOGMzbDIta3NwRHFSNEdJRVcyUWlZVkZRQkVrQkxDZEtMUWs?oc=5\" target=\"_blank\">Amgen: Stagnation And The IRS Are Coming (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-04T14:25:03+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "The Los Angeles Sports & Entertainment Commission (LASEC) Names Amgen as Official Biotech Partner and Los Angeles World Cup 2026 Host City Supporter Ahead of FIFA World Cup 2026™ - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMizwJBVV95cUxOQkNJQTNKNEhOeTRuNjVyci14azJHejdvWlFKQkh3OFhxOWNfSDdrQmItM2xJS2U3Zm1TYUNYaTNLY3VxU3AzZndCSjJDVUF6a2JldmRCd1VxV2FkYzREanMzSVF6Z2NFQTdrZXl1YVlnZEozck9rR3FVaWZ4TG5ZRnJGY18zX25Zc2JValVqaVE3a3pLckFXckZqZU5aUDdsM19FSmlPS3kyT1ZxOXJfMmtqSVcxajNxSVVyaWwwa0xycE1qc1hKc1AxYVlnaDJRWWVLLWY0M2RyTFpBMHdBRDVXNXQxOEx4amlyWjJzbURLNm9oSmxia0ctSGRpWmc0RTNSTTFCcU9maElLR1pYVko5VVZkVnVZRm1HTllPcFZ1cGpnNU52ZTFXaEdFbDJndlZwZlRCak9pSENOZFh6eWJzUzZBU3RGcTdMMUpubw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizwJBVV95cUxOQkNJQTNKNEhOeTRuNjVyci14azJHejdvWlFKQkh3OFhxOWNfSDdrQmItM2xJS2U3Zm1TYUNYaTNLY3VxU3AzZndCSjJDVUF6a2JldmRCd1VxV2FkYzREanMzSVF6Z2NFQTdrZXl1YVlnZEozck9rR3FVaWZ4TG5ZRnJGY18zX25Zc2JValVqaVE3a3pLckFXckZqZU5aUDdsM19FSmlPS3kyT1ZxOXJfMmtqSVcxajNxSVVyaWwwa0xycE1qc1hKc1AxYVlnaDJRWWVLLWY0M2RyTFpBMHdBRDVXNXQxOEx4amlyWjJzbURLNm9oSmxia0ctSGRpWmc0RTNSTTFCcU9maElLR1pYVko5VVZkVnVZRm1HTllPcFZ1cGpnNU52ZTFXaEdFbDJndlZwZlRCak9pSENOZFh6eWJzUzZBU3RGcTdMMUpubw?oc=5\" target=\"_blank\">The Los Angeles Sports & Entertainment Commission (LASEC) Names Amgen as Official Biotech Partner and Los Angeles World Cup 2026 Host City Supporter Ahead of FIFA World Cup 2026™</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-12-05T14:00:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Erste Group upgrades Amgen stock rating to Buy from Hold on obesity drug - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQRkx0amdHcnJuTld1ckFyTUhuWFVIbXRzOW0xQU5XVHNGOFdXbE9pLXJ2MmZ4N2M2RFZxVDhaZWUtUzAwdV90ZHNoMTA2T3lMa1VmQWlJYmFJRnFvNUFUdGpGQU5qNktpd19kYXFjWmc4UVUwOWVyZk5oaWtOb2t4VE44UW1PZm1sYWlnR1FmRUJDM0doQjR0b3BqTmtpUUU0WXZPcTBIX0JzSzlZTGJBV2NvOEtudGMxMHdQOEIyTTM0RGFFV1hCbm01alQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMizAFBVV95cUxQRkx0amdHcnJuTld1ckFyTUhuWFVIbXRzOW0xQU5XVHNGOFdXbE9pLXJ2MmZ4N2M2RFZxVDhaZWUtUzAwdV90ZHNoMTA2T3lMa1VmQWlJYmFJRnFvNUFUdGpGQU5qNktpd19kYXFjWmc4UVUwOWVyZk5oaWtOb2t4VE44UW1PZm1sYWlnR1FmRUJDM0doQjR0b3BqTmtpUUU0WXZPcTBIX0JzSzlZTGJBV2NvOEtudGMxMHdQOEIyTTM0RGFFV1hCbm01alQ?oc=5\" target=\"_blank\">Erste Group upgrades Amgen stock rating to Buy from Hold on obesity drug</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-12-05T15:44:35+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Does Amgen Stock Lead the Pack? - Trefis",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNQnJYaDU3NjU5ekc3akZ1Sl9TeVdxM3FRZW9ROEJDcnY1VEJNOGpXXy1kWi03d0VfclphT1FkWHhBQ0pTdlB5REVJS0FJWVZzb095cVVMakEyeE95Zy0zbmxvWHItTzNuTWFCZUtaN2llc2ZRUDg4YTY3YjNSSjEtcGFHcDVHTmpoa3g0eDBMaXg2X0xIZkJKaVBVX1Fyekhuc2Qw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNQnJYaDU3NjU5ekc3akZ1Sl9TeVdxM3FRZW9ROEJDcnY1VEJNOGpXXy1kWi03d0VfclphT1FkWHhBQ0pTdlB5REVJS0FJWVZzb095cVVMakEyeE95Zy0zbmxvWHItTzNuTWFCZUtaN2llc2ZRUDg4YTY3YjNSSjEtcGFHcDVHTmpoa3g0eDBMaXg2X0xIZkJKaVBVX1Fyekhuc2Qw?oc=5\" target=\"_blank\">Does Amgen Stock Lead the Pack?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Trefis</font>",
      "published": "2025-12-04T11:59:16+00:00",
      "source": "Trefis"
    },
    {
      "title": "Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNc0pjZjFhcktfYnNMRFdIb3pOOFR5bXBGQzlzWjQ5WXhuX0dDSUdMRTM5bXZ0cVdPYWRaWUZoX25RVXRmX1EwVTVtblVUcHdSQU12WndmU1d2UWlpSUpBMDVoVnFnLXJGR243LWswYlVXRDJVZlgwLTFDeFFDd0NhYlV3TE8tQTlfNklyRXVfQWdqbkVPNGl2Z1M2TUFnQnp5dW40?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNc0pjZjFhcktfYnNMRFdIb3pOOFR5bXBGQzlzWjQ5WXhuX0dDSUdMRTM5bXZ0cVdPYWRaWUZoX25RVXRmX1EwVTVtblVUcHdSQU12WndmU1d2UWlpSUpBMDVoVnFnLXJGR243LWswYlVXRDJVZlgwLTFDeFFDd0NhYlV3TE8tQTlfNklyRXVfQWdqbkVPNGl2Z1M2TUFnQnp5dW40?oc=5\" target=\"_blank\">Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-02T13:00:35+00:00",
      "source": "Amgen"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance - TradingView",
      "link": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN09XMkFVU05lZ0ZfVnZnbzkzU3NuNklBWEhsUWtkbVpTOHhHVHEzbk5PSEpGVEY1dUFjLTFLY3U5ZUg1RlhWZm1MR2hqNEd2ZWotTmx5T20wZjhseDBNcTdkdXlELXJvZjRZUVpDR1VXYTdtWmxHX3ZRLXFnRFBIb3VfWk4wSk5fV0ZoNGVSNFNhbkZqUHBhZXc2a0lQZ2Exa2w4eVJZakRFSk5uczBZcmJvSnlXVWRVNHQyV1M0MDZXd2l6X3dFbk5ua0p2UE1VUV9HV0xFS1ppLXZEdFJmRllmR1A1QQ?oc=5\" target=\"_blank\">AMGN Q3 Deep Dive: Broad-Based Product Momentum and Pipeline Progress Drive Upbeat Guidance</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TradingView</font>",
      "published": "2025-11-05T08:00:00+00:00",
      "source": "TradingView"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-05",
      "close": 329.8900146484375
    },
    "history": [
      {
        "date": "2025-11-26",
        "close": 344.57000732421875
      },
      {
        "date": "2025-11-28",
        "close": 345.4599914550781
      },
      {
        "date": "2025-12-01",
        "close": 337.489990234375
      },
      {
        "date": "2025-12-02",
        "close": 338.3599853515625
      },
      {
        "date": "2025-12-03",
        "close": 345.4200134277344
      },
      {
        "date": "2025-12-04",
        "close": 340.1600036621094
      },
      {
        "date": "2025-12-05",
        "close": 329.8900146484375
      }
    ],
    "name": "Amgen Inc."
  }
}